Advanced Enclomiphene + HCG 5000 IU + Tamoxifen PCT Stack (Driada Medical)

Comprehensive HPTA Recovery: Clinical Synergy of HCG, Enclomiphene & Tamoxifen

Restoring endogenous endocrine balance following suppressive anabolic regimens requires a precise, biphasic therapeutic approach. The Advanced Enclomiphene + HCG 5000 IU + Tamoxifen PCT Stack by Driada Medical delivers the pinnacle of evidence-based endocrine recovery. Available among our premier Ready PCT Stacks, this protocol initiates with Human Chorionic Gonadotropin (HCG) to directly stimulate testicular Leydig cells via LH-receptor agonism, reversing intratesticular atrophy before oral SERM administration. This essential primer restores testicular responsiveness, allowing subsequent selective estrogen receptor modulators to operate at maximum physiological efficiency without cellular desensitisation.

Once testicular sensitivity is re-established, the stack transitions to a synergistic combination of Enclomilad (pure trans-isomer enclomiphene citrate) and Tamoxifen Citrate. Selecting comprehensive Post Cycle Therapy (PCT) ensures selective competitive antagonism at hypothalamic and pituitary estrogen receptors. Unlike conventional mixed-isomer agents, enclomiphene removes negative feedback without the pro-estrogenic and mood-destabilising liabilities of zuclomiphene. Paired with Nolvados, this combination accelerates the release of endogenous GnRH, LH, and FSH, preserving lean muscle mass and restoring natural androgen synthesis rapidly.

Complete Kit Package Components

• 1 × HCG 5000iu (Human chorionic gonadotropin) | 5000iu+water/vial
• 1 × Enclomilad 12.5 mg (Enclomiphene citrate) - Driada | 50tabs | 12,5 mg/tab
• 1 × Tamoxifen Citrate 10 mg (Nolvados) | 100 Tabs

Phase-by-Phase Administration Schedule

Administration Guidelines & Clinical Cycle Timing

Execution begins during Weeks 1–2 with reconstituted Driada HCG 5000 IU. Administer 1,000 IU subcutaneously or intramuscularly every third day for a total of 5 injections. This crucial preparatory phase restores primary Leydig steroidogenesis before commencing oral SERM therapy. Initiating this sequence at the correct clearance point—tailored to the active clearance windows of preceding Steroid Cycles—prevents competing feedback inhibition. Keep reconstituted HCG refrigerated between 2°C and 8°C, and avoid concomitant high-dose SERM deployment during active gonadotropin administration to prevent early receptor desensitisation.

In Weeks 3 through 6, transition fully to oral stimulation using Enclomilad at 12.5–25 mg daily alongside Tamoxifen Citrate at 10–20 mg daily. Split dosing is unnecessary due to the stable half-lives of these compounds; administer single daily doses with meals to optimise absorption. For athletes seeking alternatives to traditional Nolvadex-only protocols, this dual-SERM design eliminates negative feedback mechanisms while protecting vascular health and lipid profiles, ensuring sustained serum testosterone recovery throughout the final phase.

Endocrine Advantages of the Driada PCT Protocol

• Biphasic Gonadal Resuscitation: Priming Leydig cells with 5,000 IU HCG directly overcomes testicular desensitisation, ensuring the subsequent hypothalamic-pituitary stimulation yields prompt and robust testosterone production.
• Superior Receptor Selectivity: Enclomilad delivers pure enclomiphene devoid of zuclomiphene, eliciting potent GnRH/LH pulsatility while eliminating emotional volatility, lethargy, and ocular disturbances commonly linked to generic anti-estrogens.
• Targeted Peripheral Estrogenic Shield: Driada Tamoxifen Citrate blocks mammary estrogen receptors competitively, offering dual protection against rebound gynecomastia while supporting optimal liver-mediated IGF-1 secretion during post-cycle catabolism.
• Muscle Retention & Systemic Stability: Accelerating free testosterone normalization rapidly mitigates post-cycle cortisol spikes, securing hard-earned nitrogen retention, physical strength, athletic vigor, and natural libido.